The independent association between serum uric acid and graft outcomes after kidney transplantation

Transplantation

Volumn 89, Issue 5, 2010, Pages 573-579

  Haririan, Abdolreza ^a   Noguiera, Joseph M ^a   Zandi Nejad, Kambiz ^b   Aiyer, Ravi ^a   Hurley, Heather ^c   Cooper, Matthew ^a   Klassen, David K ^a   Weir, Matthew R ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

Hyperuricemia; Kidney transplantation; Outcome; Uric acid

Indexed keywords

CLOTRIMAZOLE; COTRIMOXAZOLE; CREATININE; GANCICLOVIR; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; URIC ACID;

ADULT; ARTICLE; BACTERIAL INFECTION; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; HYPERURICEMIA; KIDNEY DONOR; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RENAL GRAFT DYSFUNCTION; URIC ACID BLOOD LEVEL;

ADULT; BIOLOGICAL MARKERS; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HOSPITALS, UNIVERSITY; HUMANS; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION; MALE; MARYLAND; METHYLPREDNISOLONE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REOPERATION; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; URIC ACID;

EID: 77949393690     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181c73c18     Document Type: Article

References (45)

1. SRTR. Available at: http://www.ustransplant.org/annual-reports/ current/survival-rates.htm. Accessed January 19, 2009.
2. USRDS. Available at: http://www.usrds.org/2008/view/esrd-07.asp. Accessed January 23, 2009.
3. OPTN. Available at: http://www.optn.org/latestData/rptData.asp. Accessed January 23, 2009.
4. Khosla UM, Zharikov S, Finch JL, et al. Hyperuricemia induces endo-thelial dysfunction. Kidney Int 2005; 67: 1739.
5. Kato M,Hisatome I, TomikuraY, et al. Status ofendothelial dependent vasodilation in patients with hyperuricemia. Am J Cardiol 2005; 96: 1576.
6. Gersch C, Palii SP, Kim KM, et al. Inactivation of nitric oxide by uric acid. Nucleosides Nucleotides Nucleic Acids 2008; 27: 967.
7. Kanellis J, Watanabe S, Li JH, et al. Uric acid stimulates monocyte che-moattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension 2003; 41: 1287.
8. Kang DH, Han L, Ouyang X, et al. Uric acid causes vascular smooth muscle cell proliferation by entering cells via a functional urate transporter. Am J Nephrol 2005; 25: 425.
9. Shi Y, Evans JE, Rock KL. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 2003; 425: 516.
10. Feig DI, Kang DH, Nakagawa T, et al. Uric acid and hypertension. Curr Hypertens Rep 2006; 8: 111.
11. Kang DH, Park SK, Lee IK, et al. Uric acid-induced C-reactive protein expression: Implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol 2005; 16: 3553.
12. Ruggiero C, Cherubini A, Ble A, et al. Uric acid and inflammatory markers. Eur Heart J 2006; 27: 1174.
13. Mazzali M, Kanellis J, Han L, et al. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol 2002; 282: F991.
14. Viazzi F, Parodi D, Leoncini G, et al. Serum uric acid and target organ damage in primary hypertension. Hypertension 2005; 45: 991.
15. Santos RD, Nasir K, Orakzai R, et al. Relation of uric acid levels to presence of coronary artery calcium detected by electron beam tomography in men free of symptomatic myocardial ischemia with versus without the metabolic syndrome. Am J Cardiol 2007; 99: 42.
16. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 2000; 283: 2404.
17. Verdecchia P,Schillaci G, ReboldiG,etal. Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study. Hypertension 2000; 36: 1072.
18. Short RA, Johnson RJ, Tuttle KR. Uric acid, microalbuminuria and cardiovascular events in high-risk patients. Am J Nephrol 2005; 25: 36.
19. Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med 2008; 359: 1811.
20. Navaneethan SD, Beddhu S. Associations of serum uric acid with cardiovascular events and mortality in moderate chronic kidney disease. Nephrol Dial Transplant 2009; 24: 1260.
21. Iseki K, Oshiro S, Tozawa M, et al. Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects. Hypertens Res 2001; 24: 691.
22. IsekiK,IkemiyaY,InoueT,etal. Significance ofhyperuricemia asarisk factor for developing ESRDin a screened cohort. AmJ Kidney Dis 2004; 44: 642.
23. MyllymakiJ, HonkanenT,SyrjanenJ,etal. Uric acid correlates with the severity of histopathological parameters in IgA nephropathy. Nephrol Dial Transplant 2005; 20:89.
24. Ohno I, Hosoya T, Gomi H, et al. Serum uric acid and renal prognosis in patients with IgA nephropathy. Nephron 2001; 87: 333.
25. Weiner D, Tighiouart H, Elsayed EF, et al. Uric acid and incident kidney disease in the community. J Am Soc Nephrol 2008; 19: 1204.
26. Chonchol M, Shlipak MG, Katz R, et al. Relationship of uric acid with progression of kidney disease. Am J Kidney Dis 2007; 50: 239.
27. Obermayr RP, Temml C, Gutjahr G, et al. Elevated uric acid increases the risk for kidney disease. J Am Soc Nephrol 2008; 19: 2407.
28. FukuiM,TanakaM,ShiraishiE, etal. Serum uric acidisassociated with microalbuminuria and subclinical atherosclerosis in men with type 2 diabetes mellitus. Metabolism 2008; 57: 625.
29. Lee JE, Kim YG, Choi YH, et al. Serum uric acid is associated with microalbuminuria in prehypertension. Hypertension 2006; 47: 962.
30. Tseng CH. Correlation of uric acid and urinary albumin excretion rate in patients with type 2 diabetes mellitus in Taiwan. Kidney Int 2005; 68: 796.
31. Viazzi F, Leoncini G, Ratto E, et al. Mild hyperuricemia and subclinical renal damage inuntreated primary hypertension.AmJ Hypertens 2007; 20: 1276.
32. Rosolowsky ET, Ficociello LH, Maselli NJ, et al. High-normal serum uric acid is associated with impaired glomerular filtration rate in non-proteinuric patients with type1 diabetes.Clin JAm Soc Nephrol 2008; 3: 706.
33. Feig DI, Soletsky B, Johnson RJ. Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension:A randomized trial. JAMA 2008; 300: 924.
34. Siu YP, Leung KT, Tong MK, et al. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis 2006; 47: 51.
35. Kang DH, Nakagawa T, Feng L, et al.A role for uric acid in the progression of renal disease. J Am Soc Nephrol 2002; 13: 2888.
36. Sanchez-Lozada LG, Tapia E, vila-Casado C, et al. Mild hyperuricemia induces glomerular hypertension in normal rats. Am J Physiol Renal Physiol 2002; 283: F1105.
37. Sanchez-Lozada LG, Tapia E, Santamaria J, et al. Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats. Kidney Int 2005; 67: 237.
38. Mazzali M, Kim YG, Suga S, et al. Hyperuricemia exacerbates chronic cyclosporine nephropathy. Transplantation 2001; 71: 900.
39. Mazzali M. Uric acid and transplantation. Semin Nephrol 2005; 25: 50.
40. Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713.
41. Gores PF, Fryd DS, Sutherland DE, et al. Hyperuricemia after renal transplantation. Am J Surg 1988; 156: 397.
42. Gerhardt U, Grosse HM, Hohage H. Influence of hyperglycemia and hyperuricemia on long-term transplant survival in kidney transplant recipients. Clin Transplant 1999; 13: 375.
43. Armstrong KA, Johnson DW, Campbell SB, et al. Does uric acid have a pathogenetic role in graft dysfunction and hypertension in renal transplant recipients? Transplantation 2005; 80: 1565.
44. Akalin E, Ganeshan SV, Winston J, et al. Hyperuricemia is associated with the development of the composite outcomes of new cardiovascular events and chronic allograft nephropathy.Transplantation 2008; 86: 652.
45. Akgul A, Bilgic A, Ibis A, et al. Is uric acid a predictive factor for graft dysfunction in renal transplant recipients? Transplant Proc 2007; 39: 1023.